title: Endotoxemic-like shock induced by Loxosceles spider venoms: pathological changes and putative cytokine mediators.
abstract: The systemic symptoms, tissue lesions and release of cytokines were analysed in four isogenic mouse strains with distinct haplotypes injected with various doses of Loxosceles intermedia spider venom. The estimated LD50 were 24.5 microg for C57Bl/6, 17.6 microg for BALB/c, 6.3 microg for C3H/HeJ and 4.6 microg for A/Sn mice. Prostration, acute cachexia, hypothermia, neurological disorders and hemoglobinuria were the signals preceding death. Accumulation of eosinophilic material inside the proximal and distal renal tubules and acute tubular necrosis were the most common histopathological findings. Death was prevented by previous treatment of venom with specific antivenom serum. The protein F35 purified from the whole venom retained the ability to induce the symptoms of the whole venom. The cytokines tumor necrosis factor (TNF), interleukins IL-6 and IL-10 and the radical nitric oxide were detected in serum at different levels after venom injection. These findings indicate that the state of shock produced in mice by whole endotoxin-free L. intermedia venom or by its purified fraction, protein F35, mimics the endotoxemic shock, that susceptibility to the systemic effects of the venom varies among mice of different haplotypes and that the pattern of in vivo cytokine release resembles that of endotoxemic shock.
authors.affiliation: Laboratory of Immunochemistry, Instituto Butantan, São Paulo, SP, Brazil.
authors.forename: D V
authors.initials: DV
authors.lastname: Tambourgi
authors.forename: V L
authors.initials: VL
authors.lastname: Petricevich
authors.forename: F C
authors.initials: FC
authors.lastname: Magnoli
authors.forename: S L
authors.initials: SL
authors.lastname: Assaf
authors.forename: S
authors.initials: S
authors.lastname: Jancar
authors.forename: W
authors.initials: W
authors.lastname: Dias Da Silva
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000997:Antivenins / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D007213:Indomethacin / Q000627:therapeutic use; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009500:Neutralization Tests; D012772:Shock, Septic / Q000473:pathology* / Q000503:physiopathology / Q000517:prevention & control; D013045:Species Specificity; D013111:Spider Venoms / Q000037:antagonists & inhibitors / Q000633:toxicity*
chemical_list: D000911:Antibodies, Monoclonal; D000997:Antivenins; D016861:Cyclooxygenase Inhibitors; D016207:Cytokines; D013111:Spider Venoms; D007213:Indomethacin